Dana-Farber Cancer Institute (Boston). Sidney Farber, MD, founded the Children's Cancer Research Foundation in 1947 to conduct research and provide state-of-the-art treatment to children with cancer. Dr. Farber also launched the first chemotherapy research program for children with cancer. In 1969, the foundation's mission officially expanded to include patients of all ages, and in 1983 the hospital's name was changed to its current iteration to recognize not only Dr. Farber but also the Charles A. Dana Foundation, a philanthropic organization.

Today, Dana-Farber Cancer Institute is a teaching affiliate of Boston-based Harvard Medical School, and it is also a federally designated Center for AIDS Research. The 30-bed hospital employs more than 4,000 people who treat close to 400,000 patients each year. Additionally, 510 volunteers contributed a combined 232,892 hours of service in fiscal year 2014. That same year, Dana-Farber was involved in 761 clinical trials.

Dana-Farber has clinical affiliations with several prominent healthcare organizations in the Boston area to provide patients with the best possible care, including Brigham and Women's Hospital, Boston Children's Hospital and Partners HealthCare.

In its 2015-16 rankings, U.S. News & World Report ranked Dana-Farber as No. 1 in the country for pediatric cancer care and No. 4 in the country for adult cancer care. The hospital has been designated as a Magnet hospital since 2005 by the American Nurses Credentialing Center.